Shanghai United Imaging Healthcare (688271) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 reached RMB 2.91 billion, up 17.34% year-over-year.

• Net profit attributable to shareholders was RMB 398.87 million, a 7.78% increase year-over-year.

• Total assets grew to RMB 33.23 billion, up 1.37% from the end of 2025.

Financial highlights

• Operating income rose to RMB 2.91 billion from RMB 2.48 billion year-over-year.

• Total profit increased 20.94% to RMB 481.12 million.

• Basic and diluted EPS were both RMB 0.48, up 6.67% year-over-year.

• Net cash flow from operating activities was negative RMB 959.10 million, a significant decrease from negative RMB 353.47 million last year, mainly due to increased procurement and operating payments.

• R&D investment totaled RMB 586.80 million, accounting for 20.18% of revenue.

Outlook and guidance

• Management did not provide explicit forward-looking guidance in this report.